IDYA
Price
$24.50
Change
-$0.33 (-1.33%)
Updated
Jul 25 closing price
Capitalization
2.15B
17 days until earnings call
MLTX
Price
$55.03
Change
-$0.00 (-0.00%)
Updated
Jul 25 closing price
Capitalization
3.5B
12 days until earnings call
Interact to see
Advertisement

IDYA vs MLTX

Header iconIDYA vs MLTX Comparison
Open Charts IDYA vs MLTXBanner chart's image
IDEAYA Biosciences
Price$24.50
Change-$0.33 (-1.33%)
Volume$883.55K
Capitalization2.15B
MoonLake Immunotherapeutics
Price$55.03
Change-$0.00 (-0.00%)
Volume$2.71K
Capitalization3.5B
IDYA vs MLTX Comparison Chart in %
Loading...
IDYA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MLTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IDYA vs. MLTX commentary
Jul 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IDYA is a StrongBuy and MLTX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 26, 2025
Stock price -- (IDYA: $24.50 vs. MLTX: $55.07)
Brand notoriety: IDYA and MLTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IDYA: 81% vs. MLTX: 70%
Market capitalization -- IDYA: $2.15B vs. MLTX: $3.5B
IDYA [@Biotechnology] is valued at $2.15B. MLTX’s [@Biotechnology] market capitalization is $3.5B. The market cap for tickers in the [@Biotechnology] industry ranges from $313.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IDYA’s FA Score shows that 0 FA rating(s) are green whileMLTX’s FA Score has 0 green FA rating(s).

  • IDYA’s FA Score: 0 green, 5 red.
  • MLTX’s FA Score: 0 green, 5 red.
According to our system of comparison, both IDYA and MLTX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IDYA’s TA Score shows that 4 TA indicator(s) are bullish while MLTX’s TA Score has 5 bullish TA indicator(s).

  • IDYA’s TA Score: 4 bullish, 4 bearish.
  • MLTX’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, MLTX is a better buy in the short-term than IDYA.

Price Growth

IDYA (@Biotechnology) experienced а +13.48% price change this week, while MLTX (@Biotechnology) price change was +3.73% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.58%. For the same industry, the average monthly price growth was +17.35%, and the average quarterly price growth was +27.29%.

Reported Earning Dates

IDYA is expected to report earnings on Nov 11, 2025.

MLTX is expected to report earnings on Nov 18, 2025.

Industries' Descriptions

@Biotechnology (+7.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MLTX($3.5B) has a higher market cap than IDYA($2.15B). MLTX YTD gains are higher at: 1.699 vs. IDYA (-4.669). MLTX has higher annual earnings (EBITDA): -168.14M vs. IDYA (-356.46M). IDYA has more cash in the bank: 693M vs. MLTX (480M). IDYA has less debt than MLTX: IDYA (26M) vs MLTX (75.6M). IDYA has higher revenues than MLTX: IDYA (7M) vs MLTX (0).
IDYAMLTXIDYA / MLTX
Capitalization2.15B3.5B61%
EBITDA-356.46M-168.14M212%
Gain YTD-4.6691.699-275%
P/E RatioN/AN/A-
Revenue7M0-
Total Cash693M480M144%
Total Debt26M75.6M34%
FUNDAMENTALS RATINGS
IDYA: Fundamental Ratings
IDYA
OUTLOOK RATING
1..100
13
VALUATION
overvalued / fair valued / undervalued
1..100
63
Fair valued
PROFIT vs RISK RATING
1..100
72
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
48
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IDYAMLTX
RSI
ODDS (%)
Bearish Trend 2 days ago
54%
Bearish Trend 2 days ago
83%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
58%
Momentum
ODDS (%)
Bullish Trend 2 days ago
72%
Bullish Trend 2 days ago
75%
MACD
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
63%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
75%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
76%
Advances
ODDS (%)
Bullish Trend 3 days ago
77%
Bullish Trend 13 days ago
81%
Declines
ODDS (%)
Bearish Trend 9 days ago
77%
Bearish Trend 19 days ago
73%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
59%
Aroon
ODDS (%)
Bullish Trend 4 days ago
77%
Bullish Trend 2 days ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
IDYA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MLTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
EPGCX15.29N/A
N/A
Fidelity Advisor Equity Growth C
PINDX20.72N/A
N/A
Victory Pioneer Disciplined Growth A
NMULX11.21N/A
N/A
Neuberger Berman Multi-Cap Opp I
BTSMX25.16N/A
N/A
Boston Trust SMID Cap
QMGYX12.95N/A
N/A
Invesco Advantage International Y

IDYA and

Correlation & Price change

A.I.dvisor indicates that over the last year, IDYA has been loosely correlated with CGON. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if IDYA jumps, then CGON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IDYA
1D Price
Change %
IDYA100%
-1.33%
CGON - IDYA
62%
Loosely correlated
-0.15%
IMNM - IDYA
61%
Loosely correlated
-3.29%
SYRE - IDYA
60%
Loosely correlated
+1.08%
NRIX - IDYA
60%
Loosely correlated
-0.09%
XENE - IDYA
59%
Loosely correlated
-2.29%
More